Sumitomo Mitsui Ds Asset Management Company, LTD Pfizer Inc Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

$7.99 Billion
Q1 2024

A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Pfizer Inc stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 645,626 shares of PFE stock, worth $18.1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

645,626

Previous 618,778 4.34%

Holding current value

$18.1 Million

Previous $17.8 Million 0.57%

% of portfolio

0.22%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$25.89 - $29.73 $695,094 - $798,191	26,848 Added 4.34%	645,626 $17.9 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $236,006 - $306,546	9,032 Added 1.48%	618,778 $17.8 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $1.74 Million - $2.04 Million	54,370 Added 9.79%	609,746 $20.2 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $2.78 Million - $3.21 Million	76,883 Added 16.07%	555,376 $20.4 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $1.07 Million - $1.39 Million	27,182 Added 6.02%	478,493 $19.5 Million

Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $1.05 Million - $1.38 Million	25,238 Added 5.92%	451,311 $0
Q3 2022 Oct 19, 2022	BUY	$43.76 - $53.42 $1.14 Million - $1.39 Million	25,964 Added 6.49%	426,073 $18.6 Million
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $1.12 Million - $1.32 Million	24,001 Added 6.38%	400,109 $21 Million
Q1 2022 Apr 19, 2022	BUY	$45.75 - $56.69 $48,540 - $60,148	1,061 Added 0.28%	376,108 $19.5 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $622,940 - $923,405	15,076 Added 4.19%	375,047 $22.1 Million
Q3 2021 Oct 15, 2021	SELL	$39.25 - $50.42 $1 Million - $1.29 Million	-25,585 Reduced 6.64%	359,971 $15.5 Million
Q2 2021 Jul 19, 2021	SELL	$35.91 - $40.68 $29,230 - $33,113	-814 Reduced 0.21%	385,556 $15.1 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $936,882 - $1.06 Million	27,975 Added 7.81%	386,370 $14 Million
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $46,757 - $59,456	-1,397 Reduced 0.39%	358,395 $13.2 Million
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $3.73 Million - $4.37 Million	-117,421 Reduced 24.61%	359,792 $13.2 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $310,326 - $376,471	10,303 Added 2.21%	477,213 $15.6 Million
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $564,440 - $806,462	20,882 Added 4.68%	466,910 $15.2 Million
Q4 2019 Jan 24, 2020	SELL	$32.92 - $37.36 $2.24 Million - $2.54 Million	-68,103 Reduced 13.25%	446,028 $17.5 Million
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $1.29 Million - $1.68 Million	39,852 Added 8.4%	514,131 $18.5 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $2.96 Million - $3.32 Million	-79,961 Reduced 14.43%	474,279 $20.5 Million
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $424,312 - $466,178	11,315 Added 2.08%	554,240 $23.5 Million
Q4 2018 Jan 25, 2019	SELL	$38.47 - $43.86 $258,210 - $294,388	-6,712 Reduced 1.22%	542,925 $23.7 Million
Q3 2018 Oct 15, 2018	SELL	$34.47 - $41.81 $1.03 Million - $1.25 Million	-29,815 Reduced 5.15%	549,637 $24.2 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $540,311 - $576,026	16,383 Added 2.91%	579,452 $21 Million
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $11,998 - $13,919	-376 Reduced 0.07%	563,069 $20 Million
Q4 2017 Jan 25, 2018	SELL	$33.26 - $35.29 $139,226 - $147,723	-4,186 Reduced 0.74%	563,445 $20.4 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $17.6 Million - $19.4 Million	567,631	567,631 $20.3 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Account

Sumitomo Mitsui Ds Asset Management Company, LTD Pfizer Inc Transaction History